Revision 3 of EMA Guideline on Good Pharmacovigilance Practices (GVP): Annex I – Definitions was updated on the 25 April 2014
Revision 3 includes the following:
- Amendments of definitions of Missing information (including its explanatory note) and Risk minimisation activity in accordance with revision 1 of GVP Module V